Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy

Among breast cancer patients treated with neoadjuvant chemotherapy (NAC) and mastectomy, locoregional recurrence (LRR) rates are unclear in women with ER+ tumors treated with adjuvant endocrine therapy without postmastectomy radiation (PMRT). To determine if PMRT is needed in these patients, we comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandula, Shravan, Switchenko, Jeffrey M., Harari, Saul, Fasola, Carolina, Mister, Donna, Yu, David S., Zelnak, Amelia B., Torres, Mylin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523670/
https://www.ncbi.nlm.nih.gov/pubmed/26266050
http://dx.doi.org/10.1155/2015/147476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523670/
https://www.ncbi.nlm.nih.gov/pubmed/26266050
http://dx.doi.org/10.1155/2015/147476

Ejemplares similares